Back to YC Companies
Canos
Fall 2026
Active
AI-powered blood test to detect cancer in dogs (and cats soon).
Canos at a glance
- Y Combinator batch
- Fall 2026
- Status
- Active
- Industry
- Healthcare
- Team size
- Not recorded
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Canos
Canos is bringing a human-grade liquid biopsy platform for dogs, starting with a single blood draw. We sequence cell-free DNA to perform multi-modal analysis of fragmentation, copy number variation, native methylation (5mC and 5hmC) and more to detect cancer signals. Owners bank a healthy baseline for their dog and track changes every year. Dogs already diagnosed get personalized monitoring through treatment. We partner with mobile vets and vet clinics to serve SF and NYC. Our mission is to make pet cancer curable through early detection and monitoring.
Tags:
Anti-Aging
Diagnostics
Biotechnology